Lior Greenbaum

3.1k total citations
85 papers, 1.7k citations indexed

About

Lior Greenbaum is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Lior Greenbaum has authored 85 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 28 papers in Genetics and 20 papers in Neurology. Recurrent topics in Lior Greenbaum's work include Parkinson's Disease Mechanisms and Treatments (19 papers), Genetics and Neurodevelopmental Disorders (16 papers) and Genetic Associations and Epidemiology (11 papers). Lior Greenbaum is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (19 papers), Genetics and Neurodevelopmental Disorders (16 papers) and Genetic Associations and Epidemiology (11 papers). Lior Greenbaum collaborates with scholars based in Israel, United States and Canada. Lior Greenbaum's co-authors include Bernard Lerer, Zvi Malik, Amihai Rigbi, Yoav Kohn, Doron Lancet, Edna Ben‐Asher, Kyra Kanyas, Anna Alkelai, Chana Rothmann and Sharon Hassin‐Baer and has published in prestigious journals such as PLoS ONE, Brain and Diabetes Care.

In The Last Decade

Lior Greenbaum

81 papers receiving 1.7k citations

Peers

Countries citing papers authored by Lior Greenbaum

Since Specialization

Citations

This map shows the geographic impact of Lior Greenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lior Greenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lior Greenbaum more than expected).

Fields of papers citing papers by Lior Greenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lior Greenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lior Greenbaum. The network helps show where Lior Greenbaum may publish in the future.

Co-authorship network of co-authors of Lior Greenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Lior Greenbaum. A scholar is included among the top collaborators of Lior Greenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lior Greenbaum. Lior Greenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multipolar Electrograms 2024 ·JACC. Clinical electrophysiology ·Elad Anter, (unknown), Lior Greenbaum, (unknown), Arwa Younis, Hagai Yavin, (unknown), Michael Barkagan	5
2	Are rare heterozygous SYNJ1 variants associated with Parkinson’s disease? 2024 ·npj Parkinson s Disease ·Konstantin Senkevich, (unknown), (unknown), Eric Yu, Jamil Ahmad, Jennifer A. Ruskey, Farnaz Asayesh, (unknown), Cheryl Waters, Oury Monchi, Yves Dauvilliers, Nicolas Dupré, Irina Miliukhina, (unknown), Anton Emelyanov, Sofya Pchelina, Lior Greenbaum, Sharon Hassin‐Baer, Roy N. Alcalay, Ziv Gan‐Or	0
3	Levodopa-carbidopa intestinal gel for advanced Parkinson's disease: Impact of LRRK2 and GBA1 mutations 2024 ·Parkinsonism & Related Disorders ·Avner Thaler, (unknown), (unknown), (unknown), (unknown), (unknown), Lior Greenbaum, (unknown), (unknown), H. Shabtai, Roy N. Alcalay, Ruth Djaldetti, Sharon Hassin‐Baer, (unknown), (unknown), Nir Giladi, Tanya Gurevich	1
4	Adult-onset Alexander disease among patients of Jewish Syrian descent 2023 ·Neurogenetics ·(unknown), (unknown), (unknown), (unknown), Orit H. Lesman‐Segev, Nofar Mor, Ortal Barel, Dan Dominissini, (unknown), Elon Pras, Lior Greenbaum, Sharon Hassin‐Baer	3
5	Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features 2023 ·Annals of Clinical and Translational Neurology ·Amir Dori, Michael Arad, Yishay Wasserstrum, Arthur Pollak, (unknown), Merav Ben‐David, (unknown), (unknown), Efrat Shavit‐Stein, Liran Domachevsky, Rafael Kuperstein, Dan Dominissini, (unknown), Menachem Sadeh, Elon Pras, Lior Greenbaum	3
6	Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations 2020 ·Brain ·Uladzislau Rudakou, Eric Yu, Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Yves Dauvilliers, Dan Spiegelman, Lior Greenbaum, Stanley Fahn, Cheryl Waters, Nicolas Dupré, Guy A. Rouleau, Sharon Hassin‐Baer, Edward A. Fon, Roy N. Alcalay, Ziv Gan‐Or	29
7	Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease 2020 ·Movement Disorders ·Eric Yu, Uladzislau Rudakou, Lynne Krohn, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh, Mehrdad A. Estiar, Dan Spiegelman, Matthew Surface, Stanley Fahn, Cheryl Waters, Lior Greenbaum, Alberto J. Espay, Yves Dauvilliers, Nicolas Dupré, Guy A. Rouleau, Sharon Hassin‐Baer, Edward A. Fon, Roy N. Alcalay, Ziv Gan‐Or	29
8	Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease 2020 ·Neurobiology of Aging ·(unknown), Ramit Ravona‐Springer, Anna Alkelai, Eric Yu, Ziv Gan‐Or, Ithamar Ganmore, Anthony Heymann, Michal Schnaider Beeri, Lior Greenbaum	5
9	Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease 2020 ·Neurobiology of Aging ·Prabhjyot Saini, Uladzislau Rudakou, Eric Yu, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Stanley Fahn, Cheryl Waters, Oury Monchi, Yves Dauvilliers, Nicolas Dupré, Lior Greenbaum, Sharon Hassin‐Baer, Alberto J. Espay, Guy A. Rouleau, Roy N. Alcalay, Edward A. Fon, Ronald B. Postuma, Ziv Gan‐Or	25
10	Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations 2018 ·Parkinsonism & Related Disorders ·Gilad Yahalom, Lior Greenbaum, Simon Israeli‐Korn, (unknown), (unknown), Jennifer A. Ruskey, (unknown), Armaghan Alam, Ziv Gan‐Or, Sharon Hassin‐Baer	60
11	Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes 2016 ·Diabetes Care ·Abigail Livny, Ramit Ravona‐Springer, Anthony Heymann, (unknown), Tammar Kushnir, Galia Tsarfaty, (unknown), (unknown), (unknown), Itzik Cooper, Lior Greenbaum, Jeremy M. Silverman, Mary Sano, Sterling C. Johnson, Barbara B. Bendlin, Michal Schnaider Beeri	29
12	The impact of early versus late levodopa administration 2016 ·Journal of Neural Transmission ·Gilad Yahalom, Oren Cohen, (unknown), Chen Sarbagili‐Shabat, (unknown), (unknown), Simon Israeli‐Korn, (unknown), Lior Greenbaum, Sharon Hassin‐Baer	6
13	The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes 2014 ·European Neuropsychopharmacology ·Lior Greenbaum, (unknown), Michael W. Lutz, Anthony Heymann, (unknown), Itzik Cooper, Efrat Kravitz, Mary Sano, Allen D. Roses, Jeremy M. Silverman, Ann M. Saunders, Michal Schnaider Beeri	22
14	The Melanocortin 1 Receptor (Mc1r) Variants Do Not Account for the Co-occurrence of Parkinson's Disease and Malignant Melanoma 2014 ·Journal of Molecular Neuroscience ·(unknown), Rivka Inzelberg, Lior Greenbaum, Oren Cohen, Gilad Yahalom, Yael Laitman, Ruth Djaldetti, (unknown), Alon Scope, Esther Azizi, Eitan Friedman, Sharon Hassin‐Baer	9
15	Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease 2013 ·Frontiers in Neuroscience ·Lior Greenbaum, Mordechai Lorberboym, Eldad Melamed, Amihai Rigbi, Yael Barhum, Yoav Kohn, (unknown), Bernard Lerer, Ruth Djaldetti	15
16	Do Tardive Dyskinesia and l-Dopa Induced Dyskinesia Share Common Genetic Risk Factors? An Exploratory Study 2013 ·Journal of Molecular Neuroscience ·Lior Greenbaum, Stefano Goldwurm, (unknown), Tzuri Lifschytz, Oren Cohen, Gilad Yahalom, Roberto Cilia, Silvana Tesei, Rosanna Asselta, Rivka Inzelberg, Yoav Kohn, Sharon Hassin‐Baer, Bernard Lerer	9
17	Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia 2010 ·Movement Disorders ·Lior Greenbaum, Anna Alkelai, Amihai Rigbi, Yoav Kohn, Bernard Lerer	36
18	Proteasomal degradation regulates expression of porphobilinogen deaminase (PBGD) mutants of acute intermittent porphyria 2006 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Lior Greenbaum, (unknown), Zvi Malik	12
19	Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes 2005 ·Molecular Psychiatry ·Lior Greenbaum, Kyra Kanyas, Osnat Karni, Yifat Merbl, Tsviya Olender, (unknown), A Yakir, Doron Lancet, Edna Ben‐Asher, Bernard Lerer	86
20	Nuclear distribution of porphobilinogen deaminase (PBGD) in glioma cells: a regulatory role in cancer transformation? 2002 ·British Journal of Cancer ·Lior Greenbaum, Yael Gozlan, (unknown), Don J. Katcoff, Zvi Malik	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact